Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

Abstract

Large, long-term, open follow-up in multiple European countries of wide spectrum of patients estimating demographic, clinical and laboratory outcomes with prediction of retention of therapy

Keywords

• clinical and laboratory outcomes
• biologic therapy
• abatacept
• observational study